• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Foxp3 expression in p53-dependent DNA damage responses.Foxp3 在 p53 依赖性 DNA 损伤反应中的表达。
J Biol Chem. 2010 Mar 12;285(11):7995-8002. doi: 10.1074/jbc.M109.047985. Epub 2010 Jan 14.
2
Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.通过靶向R2的短发夹RNA稳定抑制核糖核苷酸还原酶的R2亚基,可使p53基因敲除的HCT-116结肠癌细胞对DNA损伤剂和核糖核苷酸还原酶抑制剂敏感。
J Biol Chem. 2004 Jun 25;279(26):27030-8. doi: 10.1074/jbc.M402056200. Epub 2004 Apr 19.
3
Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.Mdm2 抑制通过激活 p73 和 E2F1 介导的 PUMA 和 Siva-1 的表达诱导 p53 缺陷型人结肠癌细胞凋亡。
Apoptosis. 2011 Jan;16(1):35-44. doi: 10.1007/s10495-010-0538-0.
4
Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes.Nutlin-3对p53-Mdm2复合物的破坏揭示了不同的癌细胞表型。
Ethn Dis. 2008 Spring;18(2 Suppl 2):S2-1-8.
5
Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.顺铂联合 MDM2 抑制以双峰方式下调 Rad51 重组酶,抑制同源重组并增强肿瘤细胞杀伤。
Mol Pharmacol. 2020 Apr;97(4):237-249. doi: 10.1124/mol.119.117564. Epub 2020 Feb 16.
6
Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.Mdm2连接酶失活突变体不会以显性负性方式发挥作用来重新激活p53,反而会促进肿瘤细胞生长。
Anticancer Res. 2003 Jul-Aug;23(4):3167-74.
7
Regulation of p53 stability and function in HCT116 colon cancer cells.HCT116结肠癌细胞中p53稳定性和功能的调控
J Biol Chem. 2004 Feb 27;279(9):7598-605. doi: 10.1074/jbc.M311732200. Epub 2003 Dec 9.
8
Bioluminescence detection of cells having stabilized p53 in response to a genotoxic event.对因基因毒性事件而使p53稳定的细胞进行生物发光检测。
Mol Imaging. 2004 Jan;3(1):63-8. doi: 10.1162/15353500200403175.
9
Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.WIP1磷酸酶的抑制使乳腺癌细胞对基因毒性应激和MDM2拮抗剂Nutlin-3敏感。
Oncotarget. 2016 Mar 22;7(12):14458-75. doi: 10.18632/oncotarget.7363.
10
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.小鼠双微体拮抗剂Nutlin-3a通过激活E2F1增强化疗诱导的p53突变癌细胞凋亡。
Oncogene. 2007 May 24;26(24):3473-81. doi: 10.1038/sj.onc.1210136. Epub 2006 Dec 4.

引用本文的文献

1
p53: A player in the tumor microenvironment.p53:肿瘤微环境中的一个参与者。
Oncol Res. 2025 Mar 19;33(4):795-810. doi: 10.32604/or.2025.057317. eCollection 2025.
2
TP53 Codon 72 Polymorphism Impacts Macrophage Activation through Reactive Oxygen Species-Dependent Cell Signaling Alterations.TP53 密码子 72 多态性通过活性氧依赖性细胞信号改变影响巨噬细胞活化。
J Immunol. 2024 Dec 15;213(12):1844-1857. doi: 10.4049/jimmunol.2400212.
3
Regulation of immunological tolerance by the p53-inhibitor iASPP.p53 抑制剂 iASPP 对免疫耐受的调控。
Cell Death Dis. 2023 Feb 6;14(2):84. doi: 10.1038/s41419-023-05567-9.
4
The Role of FOXP3 on Tumor Metastasis and Its Interaction with Traditional Chinese Medicine.FOXP3 在肿瘤转移中的作用及其与中医药的相互作用。
Molecules. 2022 Oct 8;27(19):6706. doi: 10.3390/molecules27196706.
5
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies.针对 p53 突变癌症的有前途的新工具:体液和基于细胞的免疫疗法。
Front Immunol. 2021 Aug 13;12:707734. doi: 10.3389/fimmu.2021.707734. eCollection 2021.
6
and genetic variants' influence on the susceptibility and clinical course of basal cell carcinoma.以及基因变异对基底细胞癌易感性和临床病程的影响。
Postepy Dermatol Alergol. 2021 Jun;38(3):455-460. doi: 10.5114/ada.2020.93368. Epub 2020 Feb 27.
7
Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells.姜烯酚和虾青素对阿霉素细胞毒性的表观遗传免疫调节作用在激素阳性乳腺癌细胞中。
BMC Pharmacol Toxicol. 2021 Jan 28;22(1):8. doi: 10.1186/s40360-021-00473-2.
8
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.P53:免疫的守护者因突变成为其破坏者。
Int J Mol Sci. 2020 May 13;21(10):3452. doi: 10.3390/ijms21103452.
9
Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression.FOXP 家族的分子网络:双重生物学功能、与其他分子的相互作用以及在癌症进展中的临床意义。
Mol Cancer. 2019 Dec 9;18(1):180. doi: 10.1186/s12943-019-1110-3.
10
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects.索拉非尼-牛磺酸联合作用于肝癌细胞的模型:免疫学方面
Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3007-3013. doi: 10.31557/APJCP.2019.20.10.3007.

本文引用的文献

1
Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms.Notch信号通路通过RBP-J和Hes1依赖的机制调节FOXP3启动子。
Mol Cell Biochem. 2009 Jan;320(1-2):109-14. doi: 10.1007/s11010-008-9912-4. Epub 2008 Sep 6.
2
Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.人类胸腺和外周中FOXP3 +调节性T细胞的两个功能亚群。
Immunity. 2008 Jun;28(6):870-80. doi: 10.1016/j.immuni.2008.03.018. Epub 2008 May 29.
3
Foxp3 expression in human cancer cells.人类癌细胞中的Foxp3表达。
J Transl Med. 2008 Apr 22;6:19. doi: 10.1186/1479-5876-6-19.
4
FOXP3 and breast cancer: implications for therapy and diagnosis.叉头框蛋白P3与乳腺癌:对治疗和诊断的启示
Pharmacogenomics. 2007 Nov;8(11):1485-7. doi: 10.2217/14622416.8.11.1485.
5
FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.FOXP3是一种针对乳腺癌致癌基因SKP2的新型转录抑制因子。
J Clin Invest. 2007 Dec;117(12):3765-73. doi: 10.1172/JCI32538.
6
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.胰腺癌细胞中Foxp3的表达作为癌症免疫逃逸的一种新机制。
Cancer Res. 2007 Sep 1;67(17):8344-50. doi: 10.1158/0008-5472.CAN-06-3304.
7
FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.FOXP3是一种X连锁的乳腺癌抑制基因,也是HER-2/ErbB2癌基因的重要抑制因子。
Cell. 2007 Jun 29;129(7):1275-86. doi: 10.1016/j.cell.2007.04.034. Epub 2007 Jun 14.
8
Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.蛋白酶体活性调节染色质修饰和RNA聚合酶II磷酸化,以增强糖皮质激素受体介导的转录。
Mol Cell Biol. 2007 Jul;27(13):4891-904. doi: 10.1128/MCB.02162-06. Epub 2007 Apr 16.
9
Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.水飞蓟宾-磷脂酰胆碱复合物(IdB 1016)对HER-2/neu转基因小鼠乳腺肿瘤发生发展的影响。
Cancer Res. 2007 Mar 1;67(5):2022-9. doi: 10.1158/0008-5472.CAN-06-2601.
10
Thymic development and peripheral homeostasis of regulatory T cells.调节性T细胞的胸腺发育与外周稳态
Curr Opin Immunol. 2007 Apr;19(2):176-85. doi: 10.1016/j.coi.2007.02.005. Epub 2007 Feb 15.

Foxp3 在 p53 依赖性 DNA 损伤反应中的表达。

Foxp3 expression in p53-dependent DNA damage responses.

机构信息

Department of Anatomy and Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul 110-744, USA.

出版信息

J Biol Chem. 2010 Mar 12;285(11):7995-8002. doi: 10.1074/jbc.M109.047985. Epub 2010 Jan 14.

DOI:10.1074/jbc.M109.047985
PMID:20075077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832950/
Abstract

The forkhead transcription factor, Foxp3, is thought to act as a master regulator that controls (suppresses) expression of the breast cancer oncogenes, SKP2 and HER-2/ErbB2. However, the mechanisms that regulate Foxp3 expression and thereby modulate tumor development remain largely unexplored. Here, we demonstrate that Foxp3 up-regulation requires p53 function, showing that Foxp3 expression is directly regulated by p53 upon DNA damage responses in human breast and colon carcinoma cells. Treatment with the genotoxic agents, doxorubicin or etoposide, induced Foxp3 expression in p53-positive carcinoma cells, but not in cells lacking p53 function. Furthermore, knock down of endogenous wild-type p53 using RNA interference abrogated Foxp3 induction by genotoxic agents, and exogenous expression of p53 in cells lacking p53 restored the responsiveness of Foxp3 to DNA-damaging stresses. In addition, Foxp3 knock down blunted the p53-mediated growth inhibitory response to DNA-damaging agents. These results suggest that induction of Foxp3 in the context of tumor suppression is regulated in a p53-dependent manner and implicate Foxp3 as a key determinant of cell fate in p53-dependent DNA damage responses.

摘要

叉头框转录因子 Foxp3 被认为是一种主控调节因子,可控制(抑制)乳腺癌致癌基因 SKP2 和 HER-2/ErbB2 的表达。然而,调节 Foxp3 表达从而调节肿瘤发展的机制在很大程度上仍未被探索。在这里,我们证明 Foxp3 的上调需要 p53 功能,表明 Foxp3 的表达在人类乳腺癌和结肠癌细胞的 DNA 损伤反应中直接受到 p53 的调控。用致瘤药物阿霉素或依托泊苷处理诱导 p53 阳性癌细 Foxp3 的表达,但缺乏 p53 功能的细胞则不会。此外,使用 RNA 干扰敲低内源性野生型 p53 可消除致瘤剂诱导的 Foxp3 诱导作用,并且在缺乏 p53 的细胞中外源表达 p53 可恢复 Foxp3 对 DNA 损伤应激的反应性。此外,Foxp3 的敲低削弱了 p53 介导的对 DNA 损伤剂的生长抑制反应。这些结果表明,在肿瘤抑制的背景下 Foxp3 的诱导是 p53 依赖性的,并且表明 Foxp3 是 p53 依赖性 DNA 损伤反应中细胞命运的关键决定因素。